奎尼丁
部分发作
小分子
药物发现
药理学
函数增益
医学
药品
钾通道
作者
Alshaima’a M. Qunies,Kyle A. Emmitte
标识
DOI:10.4155/ppa-2022-0002
摘要
gain of function mutations have been linked to malignant migrating partial seizures of infancy. Quinidine is an anti-arrhythmic drug that functions as a moderately potent inhibitor of Slack channels; however, quinidine use is limited by its poor selectivity, safety and pharmacokinetic profile. Slack channels represent an interesting target for developing novel therapeutics for the treatment of malignant migrating partial seizures of infancy and other childhood epilepsies; thus, ongoing efforts are directed toward the discovery of small-molecules that inhibit Slack currents. This review summarizes patent applications published in 2020-2021 that describe the discovery of novel small-molecule Slack inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI